Patent On AIDS Drug Will Not Limit Access In India, Industry Argues 30/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment It is “misleading” and “counter-productive” to assert that a pharmaceutical company’s filing for a patent on a HIV/AIDS drug in India will limit access to the drug in the future, GlaxoSmithKline said in response to an objection submitted today in India. The comment is a response to the submission of a “pre-grant opposition” to the […]
Protest Submitted To First Patent Filing Of HIV/AIDS Drug In India 30/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment Two Indian HIV/AIDS networks and an international group of lawyers today submitted a protest to the first application for a patent for an HIV/AIDS drug filed in India. The opportunity to stage a “pre-grant opposition” is the “beauty of the Indian patent system,” said Ellen ‘t Hoen of Médecins Sans Frontières (MSF) in an interview. […]
Public Health And Patents Heat Up WIPO Debate On Harmonisation 08/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment Discussions at an open forum last week on a possible harmonisation of international patent laws showed that countries do not only disagree on whether it would be useful or not but also have different expectations on what such a harmonisation would encompass. Judging from the at times sharp debate, the most contentious issue seems to […]
Groups Decry Impact Of IP And Health Terms In US Trade Agreements 03/03/2006 by Martin Vaughan for Intellectual Property Watch Leave a Comment By Martin Vaughan for Intellectual Property Watch WASHINGTON, DC – Public health activists are condemning recent terms agreed to by Colombia, Peru and Central American countries in bilateral trade negotiations with the United States, that bind those countries to offer patent protections that exceed standards in multilateral agreements. The groups now are hoping for a […]
Biotech Industry Fights Disclosure In Patents On Three IP Policy Fronts 02/03/2006 by William New, Intellectual Property Watch Leave a Comment For the coming months, key biotechnology industry organisations are focusing their efforts on blocking the addition of disclosure of origin requirements in international patent applications on three fronts. The issue is being debated in three international fora: the World Trade Organization, the World Intellectual Property Organization and the Convention on Biological Diversity. Industry is mustering […]
Industry’s Take On WIPO Development Talks: An Interview With The Director General Of CropLife 24/02/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment On 22 February the biotechnology and crop industry association CropLife International hosted a side event as well as an evening reception to the ongoing discussions of a development agenda at World Intellectual Property Organization (WIPO). Intellectual Property Watch talked with CropLife Director General Christian Verschueren about what the industry thinks of the development agenda negotiations. […]
Agricultural IP Issues Debated At Industry Side Event To WIPO Meeting 24/02/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment The international crop and biotechnology industry’s concerns about current discussions on intellectual property as well as developing countries’ needs were discussed at a recent industry side event to the ongoing discussions at the World Intellectual Property Organization (WIPO). The event was hosted by the Brussels-based industry association CropLife International. On the panel were Rita Hayes, […]
El Consejo presenta a la Asamblea marco sobre I+D y resolución sobre comercio y salud 14/02/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment A finales de enero, el Consejo Ejecutivo de la Organización Mundial de la Salud (OMS) acordó presentar a la Asamblea Mundial de la Salud un proyecto de resolución sobre la necesidad de elaborar medicamentos seguros y asequibles para las enfermedades que afectan principalmente a las poblaciones más pobres del mundo. La resolución fue originalmente propuesta […]
Le Conseil de l’OMS propose un cadre en matière de recherche-développement à l’Assemblée mondiale de la Santé 13/02/2006 by William New, Intellectual Property Watch Leave a Comment Fin janvier, le Conseil exécutif de l’Organisation mondiale de la Santé (OMS) a décidé de soumettre à l’Assemblée mondiale de la Santé un projet de résolution sur la nécessité de mettre au point des médicaments sûrs et peu coûteux contre les maladies qui touchent principalement les populations les plus pauvres du monde. À l’origine, le […]
Roche Moves Through WIPO To Block Online Sales Of Tamiflu 09/02/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment Swiss pharmaceutical company Roche has won three domain name disputes at the World Intellectual Property Organization (WIPO) for website addresses that were found to use in bad faith the name of Roche’s trademark medicine, Tamiflu, touted as the best defense against avian influenza. The domain names are: www.ordertamiflunow.com, registered with eNom by Cheaptamiflu.net, Web Admin, […]